Skip to content Skip to sidebar Skip to footer

Newsletter

Tech Stocks

Test text

FortifAI (ASX:FAI) Acquires NOL8 in a Bold Play to Power the Data Future

FortifAI’s NOL8 Acquisition Signals Next-Level Ambitions in Data Processing FortifAI Limited (ASX:FAI) surged 25% today after announcing a strategic pivot into data processing through an exclusive license to commercialise NOL8 technology. For investors needing context, FortifAI was previously focused on video game development and has worked with major global brands including Lego, Disney, and Sony,…

ByCharlie YouldenDecember 15, 2025

Electric Optic Systems (ASX:EOS) Lands Major $120M Asia Military Contract, Is It Time to Buy?

EOS Fires Up Second High-Energy Laser Sale Electric Optic Systems (ASX:EOS) is moving toward a potential partnership with a South Korean venture to deliver a defence laser contract worth about A$120M. This marks the company’s second sale of a 100 kilowatt class high energy laser weapon system, following an earlier European deal. From what we…

ByCharlie YouldenDecember 15, 2025

SpaceX’s $1.5 Trillion-Dollar Lift Off in Potential 2026 IPO

SpaceX Ignites a Trillion-Dollar Push to Reach Mars by 2028 SpaceX is edging closer to what could be the first human mission to Mars by late 2028, according to recent company commentary. The more interesting question is how they plan to fund such an ambitious leap. The answer is probably not what most people expect.…

ByCharlie YouldenDecember 15, 2025

Hazer Group (ASX:HZR) Secures MOU to Power Whyalla’s Green Steel Ambition

Hazer Signs Binding MOU, Moving Closer to Commercial Hydrogen Deployment Hazer Group (ASX:HZR) announced a binding MOU that pushed the share price up 21% today. M Resources is looking to incorporate Hazer’s technology into its bid for the Whyalla steelworks in South Australia. The steelworks, currently owned by OneSteel Manufacturing, is up for sale as…

ByCharlie YouldenDecember 12, 2025

Metallium (ASX:MTM) LOI With ElementUS Marks a Strategic Step Toward US Expansion

Metallium’s LOI With ElementUS Turns U.S. Opportunity Into Execution Path Metallium (ASX:MTM) has been trading with real strength, and at first we thought this might be tied to an update on the Glencore partnership, which was expected toward the end of the year. Instead, the company announced something different but still strategically important. MTM has…

ByCharlie YouldenDecember 12, 2025

Oracle’s (NSDQ:ORCL) Growth Engine Is Running, But on Borrowed Fuel

Investors Hit Ctrl+Alt+Sell as Oracle’s Leverage Rises Oracle (NSDQ:ORCL) has just experienced one of its toughest sessions since January, falling as much as 15% before a small bounce. The market’s reaction reflects a growing concern that the company is leaning too heavily on debt to sustain its spending cycle at a time when chip demand…

ByCharlie YouldenDecember 12, 2025

Droneshield’s Back on Investors Radar, But Who’s Really Flying It?

Droneshield Takes Off Again Droneshield (ASX: DRO) shares jumped 16.2% to close at A$2.26, marking a strong rebound after a period of controversy that had weighed on sentiment. The move has sparked plenty of discussion among investors. Is this the start of institutional money rotating back in, or are traders simply taking advantage of short-term…

ByCharlie YouldenDecember 11, 2025

4DMedical’s Growth Story Gains Airflow in the US Market

4DMedical Finds Its Rhythm 4DMedical (ASX:4DX) climbed 9% today as the company continues to build strong commercial momentum with its CT:VQ lung imaging technology. Following FDA clearance in September, 4DMedical’s entry into the US market is beginning to gain real traction. The latest partnership with the University of Miami adds another major institution to its…

ByCharlie YouldenDecember 10, 2025

OpenAI AI Crown Is No Longer Untouchable

OpenAI’s Reign Faces Its First Real Test Many people have heard the headlines claiming that OpenAI is calling a code red, but most still do not understand why. When we dig into the data on market share across AI model usage, a clearer picture starts to form. What investors and users should keep in mind…

ByCharlie YouldenDecember 10, 2025

Cogstate (ASX:CGS) Sells Off 22% on Timing Delay, But the Fundamentals Stay Intact

Cogstate’s H1 Hit Is a Timing Story, Not a Demand Story Cogstate Ltd (ASX:CGS) delivered a business update this morning that reset expectations for its H1 FY26 revenue timing and margin outlook, which triggered a sharp 22% sell-off. The market reacted to near-term revenue being pushed into the back half of the year due to…

ByCharlie YouldenDecember 10, 2025